These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 633626)

  • 1. [Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)].
    Oizumi K; Watanabe A; Konno K; Hayashi I; Kawamorida K; Nagai K; Kudo S; Kurita K; Kaishio K
    Jpn J Antibiot; 1978 Jan; 31(1):15-23. PubMed ID: 633626
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on amikacin (BB-K8), a new aminoglycoside antibiotic (author's transl)].
    Kawano M; Irimajiri K; Higuchi J; Uchiyama T; Tsubura E
    Jpn J Antibiot; 1974 Aug; 27(4):446-50. PubMed ID: 4436954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
    Weidner W; Nöske HD; Sziegoleit A; Schröder R; Leidenfrost U
    Med Klin; 1979 Jul; 74(27):1071-6. PubMed ID: 470792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical results with amikacin (BB-K8) in respiratory infections (author's transl)].
    Ito T
    Jpn J Antibiot; 1976 Aug; 29(8):731-4. PubMed ID: 957522
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with amikacin for respiratory infections due to gentamicin-resistant bacteria (author's transl)].
    Ito T
    Jpn J Antibiot; 1978 Jul; 31(7):346-52. PubMed ID: 691256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience of amikacin treatment in infantile bacterial infections (author's transl)].
    Chiba S
    Jpn J Antibiot; 1974 Jun; 27(3):389-91. PubMed ID: 4436952
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on a new aminoglycoside antibiotic, amikacin (BB-K8) in pediatrics (author's transl)].
    Nakazawa S; Sato H; Watanabe O; Fujii N; Oka S
    Jpn J Antibiot; 1974 Aug; 27(4):438-45. PubMed ID: 4215904
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with amikacin for chronic complicated urinary tract infections in myelopathogenic bladder. Clinical effect against gentamicin-resistant bacteria (author's transl)].
    Konya H; Kuroda J; Iwao N; Morita M
    Jpn J Antibiot; 1978 Jul; 31(7):341-5. PubMed ID: 691255
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience with intravenous drip infusion of amikacin in urological field (author's transl)].
    Murahashi I; Toyoda A; Takasaki E
    Jpn J Antibiot; 1981 Feb; 34(2):133-9. PubMed ID: 7253190
    [No Abstract]   [Full Text] [Related]  

  • 10. [New drugs: Amikacin].
    Hofstetter A
    Urologe A; 1976 Sep; 15(5):258-9. PubMed ID: 973282
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of amikacin for respiratory infections (author's transl)].
    Takamoto M; Harada Y; Yamada H; Ishibashi T
    Jpn J Antibiot; 1979 Jun; 32(6):655-60. PubMed ID: 470135
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
    Mita T; Mayumi K; Kataoka N; Ishigami J
    Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience of amikacin intravenous drip infusion (author's transl)].
    Tsuchiya J; Miyao S; Shinonome S; Takakuwa M; Mou M
    Jpn J Antibiot; 1980 Jul; 33(7):711-5. PubMed ID: 6935444
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative clinical effect of amikacin and gentamicin on complicated urinary tract infections by doubld-blind method (author's transl)].
    Nishiura T; Kawada Y; Ichikawa T; Nakano I; Tsuji I; Kumamoto Y; Shishido S
    Nihon Hinyokika Gakkai Zasshi; 1978 Mar; 69(3):381-98. PubMed ID: 351248
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous administration of amikacin sulfate for the infections complicated with hematologic disorders (author's transl)].
    Ueda T; Takubo T; Hasegawa Y; Shibata H; Nakamura H; Masaoka T; Yoshitake J
    Jpn J Antibiot; 1977 Dec; 30(12):1021-5. PubMed ID: 271749
    [No Abstract]   [Full Text] [Related]  

  • 16. Amikacin therapy for serious gram-negative bacillary infections.
    Meyer RD; Lewis RP; Carmalt ED; Finegold SM
    Ann Intern Med; 1975 Dec; 83(6):790-800. PubMed ID: 1200524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with amikacin (BB-K8) (author's transl)].
    Nakagawa K; Watanabe K; Kabe J; Suzuki T; Koyama S
    Jpn J Antibiot; 1974 Jun; 27(3):337-42. PubMed ID: 4215897
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of absorption and excretion of powdery preparation for injection and liquid preparation of BB-K8 (amikacin) (author's transl)].
    Okubo H; Okamoto Y; Uba F; Ueda Y; Ueda T
    Jpn J Antibiot; 1975 Jun; 28(3):283-7. PubMed ID: 1152282
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of amikacin intravenous therapy in pediatrics (author's transl)].
    Nakazawa S; Sato H; Fujii N; Kojima S; Narita A; Chikaoka H; Oka S
    Jpn J Antibiot; 1980 Oct; 33(10):1104-10. PubMed ID: 7206214
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy with amikacin (BB-K8) for bacterial infections in infants and children (author's transl)].
    Nishio T; Kobayashi Y; Akaishi K; Kobayashi Y
    Jpn J Antibiot; 1974 Jun; 27(3):392-400. PubMed ID: 4612188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.